A Japan-based biotechnology company developing small-molecule therapeutics targeting protein–protein interactions (PPIs).
Students at Wagner Middle School in Winterport got a glimpse into some of the exciting STEM opportunities that could lie ...
Pharmaceutical Technology on MSN
PRISM BioLab partners with Receptor.AI for molecule discovery
The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.
MHCare Medical, a medical supply company caught up in allegations of corruption involving Alberta surgical contracts, had its office in Edmonton searched by the RCMP.
Vietnam Investment Review on MSN
PRISM BioLab and Receptor AI partner on drug discovery
TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...
Two years prior, Zhu had been arrested and indicted for his involvement with a similarly unauthorized biolab in Reedley, California. He also maintains extensive connections to the Chinese Communist ...
Contents found in Las Vegas homes owned by Reedley biolab operator Jia Bei Zhu match up with what a medical test kit company needs.
Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI —TOKYO, March 12, 2026 ...
Japan’s PRISM BioLab and USA-based Receptor.AI Inc have entered into a drug discovery collaboration agreement to develop an integrated, AI-navigated, physics-guided platform for the discovery of ...
Watch Steve Jones of St. Boniface Hospital’s Youth BIOlab on the 2026 Mega Million Choices Lottery Video Online, on GlobalNews.ca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results